TAT,PIC,TMt-PAIC

Yanhong Liu1, Bo Guo2, Guanghui Chen1

  • 1Department of Laboratory Medicine, Henan Provincial People's Hospital, People's Hospital of Zhengzhou University, People's Hospital of Henan University, Zhengzhou, Henan, China.

概括

这项研究验证了四个关键血静标志物的性能:血栓-抗血栓复合物 (TAT),α2-等离子体抑制剂-等离子体复合物 (PIC),血栓模块素 (TM) 和组织等离子体激活剂-等离子体激活剂抑制剂复合物 (t-PAIC). 结果显示,HISCL-5000分析仪适用于临床诊断.